Countries where drugs were used
| | |
In home country AND in France
|
72.2
| |
In home country AND only as substitution treatment in France
|
4.8
| |
In France AND never in home country
|
19.5
| |
Only abroad (neither in home country nor in France)
|
3.5
| |
Country of first drug use
| | |
Home country
|
77.0
| |
France
|
19.5
| |
Other
|
3.5
| |
First injection
|
Injection at least once in lifetime
| | |
No
|
4.5
| |
Yes
|
95.5
| |
Age of first injection (avg, 21.8 years old; SD, 6.2 years, 13–40 years old)
| | |
1 < 20
|
41.0
|
42.9
|
2 20–24
|
30.3
|
31.7
|
3 25–29
|
13.5
|
14.2
|
4 30+
|
10.7
|
11.2
|
N/A (never injected)
|
4.5
|
–
|
Context of 1st injection
| | |
Alone
|
26.0
|
27.2
|
With assistance of third party
|
69.5
|
72.8
|
N/A (never injected)
|
4.5
|
–
|
First product injected
| | |
Heroin
|
41.7
|
43.6
|
Cherniashka (opioid concoction)
|
16.9
|
17.7
|
Morphine
|
10.3
|
10.8
|
Opium
|
7.9
|
8.2
|
Buprenorphine (Subutex)
|
6.3
|
6.5
|
Other: morphine sulfates (Skenan, Moscontin), desomorphine, krokodil, benzodiazepines, cocaine, tranquilizers, vint
|
12.5
|
13.1
|
N/A (never injected)
|
4.5
|
–
|
Evolution of products consumed since arrival in France
|
Injection in the last month
| | |
At least one injection in the last month
|
71.1
| |
Daily injection in the last month
|
50.4
| |
Weekly injection in the last month
|
30.7
| |
Monthly injection in the last month
|
18.9
| |
Products consumed in home country
| | |
Cherniashka (opioid concoction)
|
46.7
| |
Heroin
|
21.3
| |
Pervitine, ephedrine, vint, jeff
|
14.1
| |
Crystal meth
|
9.4
| |
Desomorphine, krokodil
|
5.2
| |
Buprenorphine (Subutex, Temgesic)
|
3.4
| |
Opium
|
2.3
| |
Cocaine
|
1.6
| |
Amphetamines—speed
|
1.3
| |
Codein, morphine
|
2.6
| |
Other (brown sugar, pills/medication)
|
0.4
| |
Products consumed in France
| | |
Morphine sulfates (Skenan, Moscontin)
|
54.4
| |
Methadone
|
37.8
| |
Buprenorphine (Subutex, Temgesic)
|
33.3
| |
Cocaine
|
24.5
| |
Crack, free base
|
15.0
| |
Amphetamines—speed
|
2.3
| |
Heroin
|
2.2
| |
Opium
|
0.4
| |
Non-Adherence to harm reduction recommendations (syringe sharing)
|
Syringe sharing in the last month
|
9.3
| |
Syringe sharing since arrival in France
|
13.9
| |
Syringe sharing in home country
|
49.9
| |
Syringe sharing in lifetime
|
62.3
| |